INO 8-K 2026-11-09

INOVIO PHARMACEUTICALS, INC. (INO) 8-K dated 2026-11-09 — accession 0001193125-26-452658.

INOVIO PHARMACEUTICALS, INC. (INO) is a biotechnology company listed on US.

INOVIO PHARMACEUTICALS, INC. filed a 8-K on 2026-11-09. Accession 0001193125-26-452658.

This 8-K covers: Material agreement (Item 1.01), Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported INO revenue for 2025-12-31 was $65.3K. Net income was -$84.9M. Revenue was down 70.0% from 2024-12-31 to 2025-12-31. INO currently screens at market cap $88.0M.

Not investment advice. The INO SEC hub lists recent forms. The stock page is the research view.